Thursday, October 05, 2023 3:35:30 PM
October 05 2023 - 08:18AM
InvestorsHub NewsWire
Alert
Share On Facebook
Royal Biotek: Pioneering Biotechnology Solutions for a Thriving Future
Melbourne, FL -- October 5, 2023 -- InvestorsHub NewsWire -- Total Refinement Solutions LLC, a pioneering company in the field of pharmaceutical biotechnology and a subsidiary of Branded Legacy, Inc (OTC.PK: BLEG), is excited to announce its transition to operate under the "Doing Business As" (DBA) name, Royal Biotek. This strategic rebranding represents a significant milestone in the company's evolution and reflects its commitment to innovation, excellence, and global recognition within the biotechnology sector.
With years of dedicated expertise in the development of cutting-edge biopharmaceutical solutions, Total Refinement Solutions LLC has earned a reputation for its unwavering commitment to scientific advancement, quality, and customer satisfaction. This transition to Royal Biotek is designed to enhance our visibility and better align our brand with our mission to create a healthier and more sustainable future through biotechnology innovation.
"The transition to Royal Biotek marks an exciting new chapter in our journey," said Dave Oswald, CEO of Branded Legacy. "Our commitment to traditional ecological knowledge, new research, and providing innovative solutions to the pharmaceutical industry remains unwavering. We believe that our new name will not only strengthen our brand but also amplify our impact on global healthcare."
Customers, partners, and stakeholders can rest assured that this rebranding will not affect the company's day-to-day operations or its dedication to providing exceptional products and services. The same team of experts, with their deep industry knowledge, will continue to drive the company forward under the Royal Biotek banner.
Royal Biotek will continue to focus on:
Advancing pharmaceutical biotechnology research via Traditional Ecological Knowledge, (TEK)
Developing innovative solutions to address global healthcare challenges.
Maintaining the highest standards of quality and integrity.
Strengthening partnerships with organizations and institutions worldwide.
The transition to the Royal Biotek name will be implemented immediately, and all future business activities will be conducted under this name. The company's official website and communication channels will be updated accordingly.
For more information about Royal Biotek and its innovative pharmaceutical biotechnology solutions, please visit our website at https://royalbiotek.com.
About Royal Biotek:
Royal Biotek, formerly known as Total Refinement Solutions LLC, and a subsidiary of Branded Legacy, Inc., is a leading company in the field of pharmaceutical biotechnology. With a commitment to excellence and innovation, Royal Biotek is dedicated to developing cutting-edge solutions that contribute to a healthier and more sustainable future.
About Branded Legacy Inc.
Branded Legacy Inc. is a forward-thinking biotechnology company dedicated to driving innovation in plant-derived medicines and biotechnological breakthroughs. The company's strategic partnerships and milestone achievements highlight its commitment to transforming patient care and contributing to the advancement of healthcare solutions. More Information on the Website: https://brandedlegacy.com/
Recent BLEG News
- Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • InvestorsHub NewsWire • 05/30/2024 12:30:00 PM
- Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • InvestorsHub NewsWire • 05/22/2024 12:30:00 PM
- Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • InvestorsHub NewsWire • 05/15/2024 12:30:00 PM
- Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • InvestorsHub NewsWire • 04/16/2024 12:30:00 PM
- Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract • InvestorsHub NewsWire • 04/09/2024 12:30:00 PM
- Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation • InvestorsHub NewsWire • 04/04/2024 12:30:00 PM
- Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc. • InvestorsHub NewsWire • 03/12/2024 01:54:43 PM
- Shares of this Biotech Holdings Company Up on LOI • AllPennyStocks.com • 02/29/2024 06:10:00 PM
- Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC • InvestorsHub NewsWire • 02/29/2024 01:30:00 PM
- Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL • InvestorsHub NewsWire • 02/08/2024 01:30:00 PM
- Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market • InvestorsHub NewsWire • 02/06/2024 02:30:00 PM
- Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00 • InvestorsHub NewsWire • 01/30/2024 02:25:00 PM
- Branded Legacy, Inc. Reduces Debt by 1.5 Million • InvestorsHub NewsWire • 01/25/2024 01:30:00 PM
- Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M • InvestorsHub NewsWire • 01/23/2024 01:30:00 PM
- Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets • InvestorsHub NewsWire • 12/05/2023 01:00:00 PM
- Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • InvestorsHub NewsWire • 11/28/2023 12:23:33 PM
- Branded Legacy Signs Letter of Intent to Acquire $6 Million in Assets and Additional Facility Space • InvestorsHub NewsWire • 11/16/2023 12:00:00 PM
- Branded Legacy, Inc. Announces 1.5B Reduction in Authorized Share Count • InvestorsHub NewsWire • 11/09/2023 12:03:15 PM
- Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements • InvestorsHub NewsWire • 11/07/2023 12:02:43 PM
- Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow • InvestorsHub NewsWire • 10/26/2023 12:30:00 PM
- Rocket Web Development & Design: Navigating the Digital Frontier with Innovation and Excellence • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023 • InvestorsHub NewsWire • 10/19/2023 12:00:00 PM
- Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion • InvestorsHub NewsWire • 10/10/2023 12:25:00 PM
- Total Refinement Solutions LLC Transitions to Royal Biotek Under $BLEG Portfolio • InvestorsHub NewsWire • 10/05/2023 12:18:33 PM
- Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM